First-pass extracted concept

microbiome-targeted therapeutic interventions

Candidate: concept label1 source documents5 linked claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This is a translational concept covering interventions that aim to modify microbiome-immune interactions. The abstract presents it as a future application area rather than a defined tool.

Source 1DOIPubMed

What problem it solves

It addresses the need to translate mechanistic microbiome-immunity insights into therapies for immune-mediated disease.

Source 1DOIPubMed

What it does not solve

The abstract does not identify any specific therapeutic modality, delivery strategy, or validated intervention workflow.

Source 1DOIPubMed

Alternatives

No explicit alternative therapeutic classes are named in the abstract.

Source 1DOIPubMed

Evidence Snippets

The abstract states that the review discusses how insights into host immune-microbiome interactions may translate towards future development of microbiome-targeted therapeutic interventions.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1limitationsupports2020Source 1DOIPubMed

Current knowledge has challenges and limitations in achieving causal understanding of host immune-microbiome interactions.

Claim 2review summarysupports2020Source 1DOIPubMed

In genetically susceptible hosts and defined environmental contexts, imbalances in microbiota-immunity interactions are believed to contribute to immune-mediated disorders.

Claim 3review summarysupports2020Source 1DOIPubMed

The commensal microbiota plays critical roles in training and development of major components of the host innate and adaptive immune system.

Claim 4review summarysupports2020Source 1DOIPubMed

The immune system helps maintain key features of host-microbe symbiosis.

Claim 5translational outlooksupports2020Source 1DOIPubMed

Insights into microbiome-immunity interactions may support future development of microbiome-targeted therapeutic interventions.